VHP.NZ
Vital Healthcare Property Trust [VHP.NZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VHP.NZ Stock Summary
Top 10 Correlated ETFs
VHP.NZ
Top 10 Correlated Stocks
VHP.NZ
In the News
VHP.NZ Financial details
Company Rating
Sell
Market Cap
1.48B
Income
-132.24M
Revenue
333.67M
Book val./share
2.72
Cash/share
0.02
Dividend
0.1
Dividend %
4.42%
Employees
25
Optionable
No
Shortable
Yes
Earnings
15 Feb 2024
P/E
-9.49
Forward P/E
-
PEG
0.71
P/S
8.63
P/B
0.74
P/C
107.5
P/FCF
-
Quick Ratio
0.32
Current Ratio
2.22
Debt / Equity
0.69
LT Debt / Equity
0.69
-
-
EPS (TTM)
-0.18
EPS next Y
-
EPS next Q
-
EPS this Y
-143.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
8.99%
Revenue Q/Q
-3.55%
EPS Q/Q
-5.56%
-
-
-
-
SMA20
0.46%
SMA50
-0.91%
SMA100
4.83%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-0.03%
Gross Margin
65%
Oper. Margin
-57%
Profit Margin
-89%
Payout
-33%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.95-2.42
52W High
+7.5%
52W Low
+115%
RSI
47.34
Rel Volume
0.22
Avg Volume
298.75K
Volume
64.31K
Perf Week
-0.46%
Perf Month
3.86%
Perf Quarter
3.37%
Perf Half Y
3.37%
-
-
-
-
Beta
0.506
-
-
Volatility
0.02%, 0.02%
Prev Close
-1.38%
Price
2.15
Change
0%
VHP.NZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.25 | 0.25 | 0.25 | 0.25 | 0.26 | |
| Net income per share | 0.21 | 0.13 | 0.56 | 0.53 | -0.23 | |
| Operating cash flow per share | 0.09 | 0.1 | 0.11 | 0.11 | 0.11 | |
| Free cash flow per share | 0.09 | 0.1 | 0.11 | 0.11 | 0.11 | |
| Cash per share | 0.01 | 0.01 | 0.01 | 0.04 | 0.02 | |
| Book value per share | 2.31 | 2.38 | 3 | 3.81 | 2.98 | |
| Tangible book value per share | 2.31 | 2.38 | 3 | 3.81 | 2.98 | |
| Share holders equity per share | 2.31 | 2.38 | 3 | 3.81 | 2.98 | |
| Interest debt per share | 1.7 | 1.86 | 1.92 | 1.84 | 1.95 | |
| Market cap | 1.09B | 1.13B | 1.54B | 1.54B | 1.54B | |
| Enterprise value | 1.82B | 1.94B | 2.47B | 2.53B | 2.77B | |
| P/E ratio | 11.7 | 19.38 | 5.54 | 5.06 | -10.08 | |
| Price to sales ratio | 9.81 | 9.84 | 12.23 | 10.7 | 8.96 | |
| POCF ratio | 26.9 | 25.35 | 27.26 | 25.4 | 20.87 | |
| PFCF ratio | 26.9 | 25.35 | 27.26 | 25.4 | 20.87 | |
| P/B Ratio | 1.06 | 1.04 | 1.03 | 0.71 | 0.78 | |
| PTB ratio | 1.06 | 1.04 | 1.03 | 0.71 | 0.78 | |
| EV to sales | 16.35 | 16.94 | 19.57 | 17.63 | 16.16 | |
| Enterprise value over EBITDA | 13.03 | 19.66 | 7.13 | 6.47 | -28.41 | |
| EV to operating cash flow | 44.83 | 43.62 | 43.64 | 41.85 | 37.61 | |
| EV to free cash flow | 44.83 | 43.62 | 43.64 | 41.85 | 37.61 | |
| Earnings yield | 0.09 | 0.05 | 0.18 | 0.2 | -0.1 | |
| Free cash flow yield | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
| Debt to equity | 0.7 | 0.76 | 0.62 | 0.47 | 0.64 | |
| Debt to assets | 0.37 | 0.39 | 0.35 | 0.3 | 0.36 | |
| Net debt to EBITDA | 5.21 | 8.23 | 2.68 | 2.54 | -12.65 | |
| Current ratio | 3.46 | 0.08 | 0.13 | 1.03 | 2.22 | |
| Interest coverage | 4.28 | 3.48 | 12.49 | 13.41 | -2.55 | |
| Income quality | 0.43 | 0.76 | 0.2 | 0.2 | -0.48 | |
| Dividend Yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | |
| Payout ratio | 0.35 | 0.58 | 0.09 | 0.1 | -0.33 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | -0.99 | -0.99 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0.11 | 0.06 | 0.1 | 0.11 | 0.09 | |
| Graham number | 3.3 | 2.62 | 6.13 | 6.76 | 3.95 | |
| ROIC | 0.07 | 0.04 | 0.12 | 0.1 | -0.03 | |
| Return on tangible assets | 0.05 | 0.01 | 0.05 | 0.09 | -0.04 | |
| Graham Net | -2.01 | -2.24 | -2.3 | -2.13 | -2.15 | |
| Working capital | 67.04M | -134.02M | -148.89M | 1.34M | 63.39M | |
| Tangible asset value | 1.03B | 3.17B | 4.14B | 2.17B | 1.96B | |
| Net current asset value | -807.48M | -1.01B | -1.14B | -1.19B | -1.36B | |
| Invested capital | 0.7 | 0.76 | 0.62 | 0.47 | 0.64 | |
| Average receivables | 1.24M | 3.25M | 3.42M | 2.04M | 4.11M | |
| Average payables | 12.19M | 12.91M | 22.29M | 28.68M | 32.43M | |
| Average inventory | 220K | 59.5K | 143.5K | 135K | 46.45M | |
| Days sales outstanding | 4.26 | 16.59 | 4.73 | 6.21 | 12.32 | |
| Days payables outstanding | 94.64 | 172.04 | 252.91 | 197.81 | 223.6 | |
| Days of inventory on hand | 0.71 | 0.46 | 2.13 | 0.17 | 568.58 | |
| Receivables turnover | 85.67 | 22 | 77.2 | 58.82 | 29.62 | |
| Payables turnover | 3.86 | 2.12 | 1.44 | 1.85 | 1.63 | |
| Inventory turnover | 514.36 | 785.24 | 171.01 | 2.09K | 0.64 | |
| ROE | 0.09 | 0.05 | 0.19 | 0.14 | -0.08 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 | |
| Net income per share | 0.31 | 0.22 | -0.05 | -0.18 | -0.17 | |
| Operating cash flow per share | 0 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Free cash flow per share | 0 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Cash per share | 0.01 | 0.04 | 0.02 | 0.02 | 0.02 | |
| Book value per share | 3.32 | 3.56 | 3.19 | 2.96 | 2.72 | |
| Tangible book value per share | 3.32 | 3.56 | 3.19 | 2.96 | 2.72 | |
| Share holders equity per share | 3.32 | 3.56 | 3.19 | 2.96 | 2.72 | |
| Interest debt per share | 1.83 | 1.67 | 1.8 | 1.88 | 1.87 | |
| Market cap | 1.7B | 1.64B | 1.47B | 1.55B | 1.47B | |
| Enterprise value | 2.68B | 2.64B | 2.64B | 2.78B | 2.71B | |
| P/E ratio | 2.49 | 3.08 | -11.87 | -3.18 | -3.26 | |
| Price to sales ratio | 25.42 | 21.29 | 17.54 | 17.59 | 17.37 | |
| POCF ratio | 0 | 42.69 | 38.78 | 43.39 | 54.73 | |
| PFCF ratio | 0 | 42.69 | 38.78 | 43.39 | 54.73 | |
| P/B Ratio | 0.94 | 0.76 | 0.71 | 0.79 | 0.81 | |
| PTB ratio | 0.94 | 0.76 | 0.71 | 0.79 | 0.81 | |
| EV to sales | 40.22 | 34.19 | 31.45 | 31.61 | 31.96 | |
| Enterprise value over EBITDA | 60.7 | 36.07 | 69.54 | 72.93 | 134.5 | |
| EV to operating cash flow | 0 | 68.56 | 69.51 | 77.95 | 100.67 | |
| EV to free cash flow | 0 | 68.56 | 69.51 | 77.95 | 100.67 | |
| Earnings yield | 0.1 | 0.08 | -0.02 | -0.08 | -0.08 | |
| Free cash flow yield | 0 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Debt to equity | 0.55 | 0.47 | 0.56 | 0.64 | 0.69 | |
| Debt to assets | 0.33 | 0.3 | 0.34 | 0.36 | 0.38 | |
| Net debt to EBITDA | 22.34 | 13.61 | 30.74 | 32.34 | 61.38 | |
| Current ratio | 0.22 | 1.03 | 0.26 | 2.22 | 0.5 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0.29 | -1.22 | -0.29 | -0.24 | |
| Dividend Yield | 0 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0 | 0.14 | -0.82 | -0.21 | -0.24 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | -0.01 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0.21 | 0 | 0.17 | 0 | |
| Graham number | 4.84 | 4.19 | 1.84 | 3.5 | 3.22 | |
| ROIC | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Return on tangible assets | 0.06 | 0.04 | -0.01 | -0.04 | -0.03 | |
| Graham Net | -2.15 | -1.99 | -2.12 | -2.13 | -2.16 | |
| Working capital | -190.93M | 1.34M | -151.3M | 63.39M | -26.27M | |
| Tangible asset value | 1.82B | 2.17B | 2.08B | 1.96B | 1.81B | |
| Net current asset value | -1.14B | -1.19B | -1.36B | -1.36B | -1.43B | |
| Invested capital | 0.55 | 0.47 | 0.56 | 0.64 | 0.69 | |
| Average receivables | 15.4M | 15.8M | 2.69M | 4.36M | 6.79M | |
| Average payables | 28.37M | 28.02M | 38.21M | 42.31M | 37.35M | |
| Average inventory | 122.5K | 12.5K | 15.64M | 62.07M | 47.41M | |
| Days sales outstanding | 39.34 | 2.85 | 3.14 | 5.92 | 8.27 | |
| Days payables outstanding | 109.45 | 93.37 | 148.42 | 93.54 | 105.82 | |
| Days of inventory on hand | 0 | 0.08 | 96.45 | 237.86 | 5.38 | |
| Receivables turnover | 2.29 | 31.58 | 28.62 | 15.2 | 10.88 | |
| Payables turnover | 0.82 | 0.96 | 0.61 | 0.96 | 0.85 | |
| Inventory turnover | 0 | 1.09K | 0.93 | 0.38 | 16.72 | |
| ROE | 0.09 | 0.06 | -0.01 | -0.06 | -0.06 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
VHP.NZ Frequently Asked Questions
What is Vital Healthcare Property Trust stock symbol ?
Vital Healthcare Property Trust is a NZ stock and trading under the symbol VHP.NZ
What is Vital Healthcare Property Trust stock quote today ?
Vital Healthcare Property Trust stock price is $2.15 today.
Is Vital Healthcare Property Trust stock public?
Yes, Vital Healthcare Property Trust is a publicly traded company.
Company Profile
- Volume Average 298.75K
- Market Capitalization 1.48B
- Employee 25
- CEO Ms. Lisa Parnell
- Headquarters Auckland,NZ
- IPO Date 2007-08-26
-
Website
https://www.vitalhealthcareproperty.co.nz 
Vital Healthcare Property Trust is a real estate investment trust externally managed by Vital Healthcare Management Limited. The firm investments in health and medical related properties in New Zealand and Australia. It undertakes acquisition or development of medical or healthcare-related properties such as surgical and medical facilities, geriatric and continuing care facilities primary healthcare facilities, and health support facilities. The fund may invest in conjunction with other health service providers. It was formerly known as ING Medical Properties Trust and Calan Healthcare Properties Trust.
